Adolfo Domenech

Adolfo Domenech

Auto-generated profile, based on publicly available information

Adolfo Domenech

Hospital Regional Universitario de Málaga, Spain

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Chest
Verified
Journal Article
Closed access
Borja G CosíoBorja G Cosío
Borja G Cosío
JSJoan B Soriano
Joan B Soriano
Jose Luis Lopez-CamposJose Luis Lopez-Campos
Jose Luis Lopez-Campos
MRMyriam Calle Rubio
Myriam Calle Rubio
JSJuan José Soler-Cataluna
Juan José Soler-Cataluna
ADAlfredo de Diego Damia
Alfredo de Diego Damia

11 July 2013 in Lung
Verified
Journal Article
Closed access
PDF file
MMMarc Miravitlles
Marc Miravitlles
CGCayo García-Polo
Cayo García-Polo
ADAdolfo Domenech
Adolfo Domenech
GVGustavo Villegas
Gustavo Villegas
FCFrancisco Conget
Francisco Conget
CRCristian de la Roza
Cristian de la Roza

1 December 2014 in Archivos de Bronconeumología
Verified
Journal Article
Closed access
COCasilda Olveira
Casilda Olveira
AMAna Muñoz
Ana Muñoz
ADAdolfo Domenech
Adolfo Domenech

17 March 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Jose Luis Lopez-CamposJose Luis Lopez-Campos
Jose Luis Lopez-Campos
MAMaria Abad Arranz
Maria Abad Arranz
CCCarmen Calero-Acuña
Carmen Calero-Acuña
FRFernando Romero-Valero
Fernando Romero-Valero
RARuth Ayerbe-García
Ruth Ayerbe-García
JCJuan J. Cruz-Rueda
Juan J. Cruz-Rueda
Previous clinical audits of COPD have provided relevant information about medical intervention in exacerbation admissions. The present study aims to evaluate adherence to current guidelines in COPD through a clinical audit. This is a pilot clinical audit performed in hospital outpatient respiratory clinics in Andalusia, Spain (eight provinces with more than 8 million inhabitants), including 9 centers (20% of the public centers in the area) between 2013 and 2014. Cases with an established diagnosis of COPD based on risk factors, clinical symptoms, and a post-bronchodilator FEV1/FVC ratio of less than 0.70 were deemed eligible. The performance of the outpatient clinics was benchmarked against three guidance documents available at the time of the audit. The appropriateness of the performance was categorized as excellent (>80%), good (60−80%), adequate (40−59%), inadequate (20−39%), and highly inadequate (<20%). During the audit, 621 clinical records were audited. Adherence to the different guidelines presented a considerable variability among the different participating hospitals, with an excellent or good adherence for symptom recording, MRC or CAT use, smoking status evaluation, spirometry, or bronchodilation therapy. The most outstanding areas for improvement were the use of the BODE index, the monitoring of treatments, the determination of alpha1-antitrypsin, the performance of exercise testing, and vaccination recommendations. The present study reflects the situation of clinical care for COPD patients in specialized secondary care outpatient clinics. Adherence to clinical guidelines shows considerable variability in outpatient clinics managing COPD patients, and some aspects of the clinical care can clearly be improved.

14 August 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
EDEsperanza Doña
Esperanza Doña
RRRocío Reinoso-Arija
Rocío Reinoso-Arija
LCLaura Carrasco-Hernandez
Laura Carrasco-Hernandez
ADAdolfo Doménech
Adolfo Doménech
ADAntonio Dorado
Antonio Dorado
Jose Luis Lopez-CamposJose Luis Lopez-Campos
Jose Luis Lopez-Campos
The need to improve health outcomes, as well as disease prognosis, has led clinicians and researchers to propose new ways of identifying COPD in its earliest forms. This initiative is based on the hypothesis that an earlier intervention would have a greater prognostic impact. However, the operational definition of a patient in the initial stages of the disease is complex, and there is still no unanimously accepted definition. GOLD has recently proposed different concepts to identify COPD in its early stages, such as COPD in young people or COPD with mild functional impairment. In addition, GOLD proposes two other concepts, called pre-COPD (symptomatic non-obstructive patients) and PRISm (preserved ratio with impaired spirometry), which aim to identify the patient at risk of developing this chronic airflow obstruction. However, despite the attractiveness of these concepts, none have been taken up universally by the medical community. A universally accepted identification of how to define COPD in its early stages is necessary as a preliminary step in order to design clinical trials to find out the best way to treat these patients. This review deals with these concepts of COPD at the onset of the disease, highlighting their importance and the problems involved in identifying them as therapeutic targets in real clinical practice.

1 August 2018 in Respiratory Medicine
Verified
Journal Article
Closed access
ADAdolfo Domenech
Adolfo Domenech
AMAna Muñoz-Montiel
Ana Muñoz-Montiel
NGNatalia García-Casares
Natalia García-Casares
JRJosé Rioja
José Rioja
PRPedro Ruiz-Esteban
Pedro Ruiz-Esteban
MSMiguel Ángel Sánchez-Chaparro
Miguel Ángel Sánchez-Chaparro